Location History:
- Koto-ku, JP (2021)
- Tokyo, JP (2014 - 2023)
Company Filing History:
19 out of 143 
5 out of 113 
1 out of 7 Years Active: 2014-2023
Title: **Katsunori Horii: A Pioneer in Nucleic Acid Research**
Introduction
Katsunori Horii is an accomplished inventor based in Tokyo, Japan, with a remarkable portfolio of 19 patents to his name. His work primarily focuses on innovations in molecular biology, particularly in the development of nucleoside derivatives and nucleic acids. Through his inventions, Horii has significantly contributed to advancements in biochemistry and biotechnology.
Latest Patents
Horii's latest patents include critical discoveries such as a novel nucleoside derivative or salt thereof, various polynucleotide synthesis reagents, methods for producing polynucleotides, and methods for generating binding nucleic acid molecules. His inventions offer new methodologies for creating biomaterials and nucleic acid molecules that effectively bind to biological targets without inhibiting their functions. These innovations are represented by sophisticated chemical formulas that exhibit diverse structural possibilities, making them vital for further research and application in the field.
Career Highlights
Throughout his career, Katsunori Horii has made notable contributions while working with prestigious organizations such as NEC Solution Innovators, Ltd. and Gunma University. His tenure in both academia and industry allows him to blend theoretical research with practical applications, thereby producing groundbreaking technologies that have the potential to influence various scientific fields.
Collaborations
Horii has collaborated with many distinguished professionals, including Iwao Waga and Jou Akitomi. These partnerships have enhanced the scope of his work, combining knowledge and expertise to facilitate innovative solutions in nucleic acid research.
Conclusion
In summary, Katsunori Horii stands out as a leading innovator in the field of nucleic acids and molecular biology. His extensive patent portfolio reflects his commitment to advancing scientific knowledge and application. With ongoing collaboration and research, Horii's contributions will likely continue to shape the landscape of biotechnology and molecular research for years to come.